Ledger.Open graph →
SEC Form D · filed January 23, 2017

Finch Therapeutics, Inc

Offering
$3.8M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Somerville, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

James Burgess · Cambridge, MADirector · PromoterZain Kassam · Cambridge, MAPromoterEric Alm · Cambridge, MAPromoterAndrew Noh · Cambridge, MAExec · Director · PromoterMark Smith · South Croydon, Victoria, Channel IslandsExec · Director · PromoterJames Burgess · Los Angeles, CADirector · PromoterEric Alm · Cambridge, MAPromoterAndrew Noh · Cambridge, MAExec · Director · PromoterMark Smith · New York, NYExec · Director · PromoterZain Kassam · Cambridge, MAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗